Similar articles for PMID: 24188002

Year	Number of Results
1982	1
1996	3
1997	5
1998	1
1999	1
2000	2
2003	2
2004	4
2005	2
2006	4
2007	3
2008	6
2009	5
2010	2
2011	5
2012	8
2013	5
2014	4
2015	6
2016	6
2017	2
2018	2
2019	4
2020	2
2021	2
2022	1
2023	1
2024	0

1

Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity.

Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH. Gourdain S, et al. J Med Chem. 2013 Dec 12;56(23):9569-85. doi: 10.1021/jm401049v. Epub 2013 Nov 19. J Med Chem. 2013. PMID: 24188002 Free article.

2

Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents.

Yadav RR, Sharma S, Joshi P, Wani A, Vishwakarma RA, Kumar A, Bharate SB. Yadav RR, et al. Bioorg Med Chem Lett. 2015 Aug 1;25(15):2948-52. doi: 10.1016/j.bmcl.2015.05.034. Epub 2015 May 21. Bioorg Med Chem Lett. 2015. PMID: 26048785

3

Synthesis, biological evaluation and molecular modeling studies of imidazo[1,2-a]pyridines derivatives as protein kinase inhibitors.

Lawson M, Rodrigo J, Baratte B, Robert T, Delehouzé C, Lozach O, Ruchaud S, Bach S, Brion JD, Alami M, Hamze A. Lawson M, et al. Eur J Med Chem. 2016 Nov 10;123:105-114. doi: 10.1016/j.ejmech.2016.07.040. Epub 2016 Jul 21. Eur J Med Chem. 2016. PMID: 27474927

4

Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase.

Trejo A, Arzeno H, Browner M, Chanda S, Cheng S, Comer DD, Dalrymple SA, Dunten P, Lafargue J, Lovejoy B, Freire-Moar J, Lim J, Mcintosh J, Miller J, Papp E, Reuter D, Roberts R, Sanpablo F, Saunders J, Song K, Villasenor A, Warren SD, Welch M, Weller P, Whiteley PE, Zeng L, Goldstein DM. Trejo A, et al. J Med Chem. 2003 Oct 23;46(22):4702-13. doi: 10.1021/jm0301787. J Med Chem. 2003. PMID: 14561090

5

Synthesis, Docking Study and Kinase Inhibitory Activity of a Number of New Substituted Pyrazolo[3,4-c]pyridines.

Sklepari M, Lougiakis N, Papastathopoulos A, Pouli N, Marakos P, Myrianthopoulos V, Robert T, Bach S, Mikros E, Ruchaud S. Sklepari M, et al. Chem Pharm Bull (Tokyo). 2017;65(1):66-81. doi: 10.1248/cpb.c16-00704. Chem Pharm Bull (Tokyo). 2017. PMID: 28049917 Free article.

6

Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.

Showalter HD, Sercel AD, Leja BM, Wolfangel CD, Ambroso LA, Elliott WL, Fry DW, Kraker AJ, Howard CT, Lu GH, Moore CW, Nelson JM, Roberts BJ, Vincent PW, Denny WA, Thompson AM. Showalter HD, et al. J Med Chem. 1997 Feb 14;40(4):413-26. doi: 10.1021/jm960689b. J Med Chem. 1997. PMID: 9046331

7

Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.

Traxler P, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N. Traxler P, et al. J Pharm Belg. 1997 Mar-Apr;52(2):88-96. J Pharm Belg. 1997. PMID: 9193132 Review.

8

DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives.

Neumann F, Gourdain S, Albac C, Dekker AD, Bui LC, Dairou J, Schmitz-Afonso I, Hue N, Rodrigues-Lima F, Delabar JM, Potier MC, Le Caër JP, Touboul D, Delatour B, Cariou K, Dodd RH. Neumann F, et al. Sci Rep. 2018 Feb 12;8(1):2859. doi: 10.1038/s41598-018-20984-z. Sci Rep. 2018. PMID: 29434250 Free PMC article.

9

Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors.

Bruel A, Bénéteau R, Chabanne M, Lozach O, Le Guevel R, Ravache M, Bénédetti H, Meijer L, Logé C, Robert JM. Bruel A, et al. Bioorg Med Chem Lett. 2014 Nov 1;24(21):5037-40. doi: 10.1016/j.bmcl.2014.09.017. Epub 2014 Sep 16. Bioorg Med Chem Lett. 2014. PMID: 25248682

10

Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.

Giraud F, Alves G, Debiton E, Nauton L, Théry V, Durieu E, Ferandin Y, Lozach O, Meijer L, Anizon F, Pereira E, Moreau P. Giraud F, et al. J Med Chem. 2011 Jul 14;54(13):4474-89. doi: 10.1021/jm200464w. Epub 2011 Jun 10. J Med Chem. 2011. PMID: 21623630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year